Literature DB >> 11313998

Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.

G Bradley1, J Irish, C MacMillan, K Mancer, I Witterick, W Hartwick, P Gullane, S Kamel-Reid, S Benchimol.   

Abstract

Oral squamous cell carcinoma (OSCC) is associated with heavy smoking and drinking, but the molecular pathway of tumorigenesis is not understood. Inactivation of the p53 tumor suppressor gene is likely to play an important role since p53 mutation is frequently found. The p14ARF tumor suppressor gene is functionally linked to p53, because it is activated by oncogenes and causes p53-dependent growth arrest and apoptosis. The relationship between p14ARF and p53 inactivation has not been described for OSCC. We studied 25 cases of OSCC to determine if there is an inverse correlation between p53 mutation and p14ARF inactivation by homozygous deletion or mutation. p53 mutation was found in 16 of 25 cases (64%), including nine missense and seven truncating mutations. While all cases with missense mutations showed abnormal accumulation of p53 protein, there were also five carcinomas which showed increased p53 staining in the absence of mutation. p14ARF deletion or mutation was found in eight cases (32%), six of which also demonstrated p53 mutation. Our findings indicate that OSCC often involves loss of both p14ARF and p53 function and suggest that inactivation of these two tumor suppressor genes are not functionally equivalent during tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313998     DOI: 10.1038/sj.onc.1204131

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population.

Authors:  Andrea Kis; Tímea Zsófia Tatár; Tamás Gáll; Róbert Boda; Ildikó Tar; Tamás Major; Pál Redl; Lajos Gergely; Krisztina Szarka
Journal:  Pathol Oncol Res       Date:  2014-04-09       Impact factor: 3.201

2.  p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Authors:  Yang Zhang; Erich M Sturgis; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

3.  A mouse model of human oral-esophageal cancer.

Authors:  Oliver G Opitz; Hideki Harada; Yasir Suliman; Ben Rhoades; Norman E Sharpless; Ralph Kent; Levy Kopelovich; Hiroshi Nakagawa; Anil K Rustgi
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

4.  Mechanisms of oral carcinogenesis induced by dibenzo[a,l]pyrene: an environmental pollutant and a tobacco smoke constituent.

Authors:  Kun-Ming Chen; Joseph B Guttenplan; Shang-Min Zhang; Cesar Aliaga; Timothy K Cooper; Yuan-Wan Sun; Joseph DelTondo; Wieslawa Kosinska; Arun K Sharma; Kun Jiang; Richard Bruggeman; Kwangmi Ahn; Shantu Amin; Karam El-Bayoumy
Journal:  Int J Cancer       Date:  2013-04-22       Impact factor: 7.396

5.  Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy.

Authors:  Xicheng Song; Erich M Sturgis; Zhigang Huang; Xiaodong Li; Chao Li; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2013-10-08       Impact factor: 4.944

6.  INK4a-ARF alterations in liver cell adenoma.

Authors:  A Tannapfel; C Busse; F Geissler; H Witzigmann; J Hauss; C Wittekind
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

7.  Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells.

Authors:  Alexandra Iulia Irimie; Cornelia Braicu; Valentina Pileczki; Bobe Petrushev; Olga Soritau; Radu Septimiu Campian; Ioana Berindan-Neagoe
Journal:  Mol Cell Biochem       Date:  2016-07-02       Impact factor: 3.396

8.  The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma.

Authors:  G Bradley; S Tremblay; J Irish; C MacMillan; G Baker; P Gullane; S Benchimol
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.